Brief: Galera Therapeutics Reports Q1 Loss Per Share $0.58

Obsidian Therapeutics

16/05/2022 13:34

May 16 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
RECENT
CORPORATE UPDATES
    * Q1 LOSS PER SHARE $0.58
    * AS OF MARCH 31, 2022, GALERA HAD CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS OF $60.9 MILLION
    * GALERA-EXISTING CASH, CASH EQUIVALENTS,SHORT-TERM
INVESTMENTS
WILL ENABLE TO FUND OPERATING EXPENSES,CAPITAL EXPENDITURE
REQUIREMENTS INTO H2 OF 2023

Source text for Eikon:  ID:nGNX5NVSsd 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))